The Rapid Diagnostics Market is expected to grow at a CAGR of 1.4% from 2022–2029 to reach $26.4 billion by 2029. A rapid diagnostic test (RDT) is a medical diagnostic test that provides diagnostic results efficiently and immediately (within 1 hour) while the patient is still at the health facility, screening site, or other health care provider.
RDT kits are widely used in hospitals and clinical laboratories for the qualitative and quantitative detection of specific antigens, antibodies, and genetic material or proteins associated with a specific health condition or disease, helping to uncover the underlying mechanisms of disease and enabling doctors and healthcare workers to make crucial medical decisions.
The growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, and emerging technological innovations are the key factors driving the growth of the global rapid diagnostics market.
Click here to: Get Sample Pages of this Report
The COVID-19 pandemic positively impacted that rapid diagnostics market in terms of revenue; however, the pandemic negatively impacted the sales of routine testing kits used mainly to screen cancer, blood glucose, cardiac markers, lipid profile, cholesterol, and other infectious diseases.
The COVID-19 pandemic led to a reduction in the number of overall diagnostic testing conducted globally due to the lockdowns and restrictions imposed by several governments worldwide, which translated further into reduced instrument installations and reduced sales of reagents and consumables; however, the loss of sales occurred in routine testing kits was compensated by high sales of COVID-19-related tests.
Governments worldwide depended on rapid diagnostic kits to screen COVID-19 infections within the population. Also, various governments took numerous initiatives to support the testing needs of their respective countries. Some of them are listed below:
Despite the supply and logistics challenges due to the COVID-19 pandemic, numerous rapid diagnostics products were launched to fulfill the demand for COVID-19 infection diagnosis in both symptomatic and asymptomatic people. In addition, to align themselves with the travel restrictions, companies operating in the market started to hold web meetings and webinars to interact with their customer and shareholders and provide product descriptions, customer demonstrations, and applications training.
Furthermore, countries worldwide have started to relax lockdown restrictions due to the lower number of new infections and the growing number of people with COVID-19 vaccinations, which is expected to propel the number of routine tests globally. Thus, the COVID-19 pandemic negatively impacted the sale of routine testing kits globally; however, high sales of COVID-19-related tests compensated for the loss of sales in routine testing kits.
Kits segment Generated Larger Proportion of Revenue Compared to Test Readers/Analysers
The kits segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment can be attributed to the rising adoption and repetitive kits usage. In addition, the growing portfolio of disease-specific kits for the early diagnosis of chronic diseases and the increasing technological advancements are other factors supporting the growth of this segment.
Immunoassays to Dominate the Market
The immunoassays segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the increasing geriatric population coupled with the high prevalence of chronic diseases, the increasing technological innovations, and the growing demand for home-based lateral flow assay kits.
Infectious Disease Segment to Register Largest Share in the Rapid Diagnostics Market by 2029
The infectious disease segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the rising prevalence of infectious diseases and the growing demand for affordable infectious disease testing in emerging markets.
Hospitals & Clinics Segment to Dominate Global Rapid Diagnostics Market
The hospitals & clinics segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the increasing number of patient visits to hospitals for availing various healthcare services, such as diagnosis, treatments, and surgeries with well-equipped operating & diagnostic rooms, the presence of highly skilled healthcare professionals, the ease of accessibility, and better health coverage for hospital-based healthcare services from various private and group insurance plans.
Asia-Pacific: Fastest Growing Regional Market
North America is estimated to command the largest share of the global rapid diagnostics market in 2022, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa. However, Asia-Pacific is expected to be the fastest-growing regional market due to the growing geriatric population, the rising prevalence of infectious & chronic diseases, and various government initiatives to promote health awareness.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past four years. The key players profiled in the global rapid diagnostics market report include Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), ACON Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), BioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).
Scope of the Report
Rapid Diagnostics Market, by Product
Rapid Diagnostics Market, by Platform
Rapid Diagnostics Market, by Application
Rapid Diagnostics Market, by End User
Global Rapid Diagnostics Market, by Geography
Key questions answered in the report:
This report provides pre & post COVID-19 market estimates.
IDT
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
4.2.2. Growing Prevalence of Infectious Diseases
4.2.3. Increasing Need for Rapid Decision-Making
4.2.4. Growing Demand for Point-of-Care (POC) Diagnostics
4.2.5. Technological Innovations
4.3. Restraints
4.3.1. Variance in Test Results
4.4. Opportunities
4.4.1. Emerging Markets
4.5. Challenges
4.5.1. Reluctance Toward Changing Existing Diagnostic Practices
4.6. The Impact of COVID-19 on the Rapid Diagnostics Market
4.7. Regulatory Affairs Analysis
4.7.1. U.S.
4.7.2. Europe
4.7.3. Asia-Pacific
4.7.4. Latin America
4.7.5. Middle East
4.8. Rapid Diagnostics: Innovations & Upcoming Technologies
5. Global Rapid Diagnostics Market, by Product
5.1. Introduction
5.2. Kits
5.2.1. Professional Kits
5.2.2. OTC Kits
5.3. Equipment
6. Global Rapid Diagnostics Market, by Platform
6.1. Introduction
6.2. Immunoassays
6.2.1. Lateral Flow Assays
6.2.2. Serological Tests
6.2.3. Other Immunoassays
6.3. Molecular Detection Tests
6.4. Other Rapid Diagnostic Platforms
7. Global Rapid Diagnostics Market, by Application
7.1. Introduction
7.2. Infectious Diseases Testing
7.2.1. COVID-19 Testing
7.2.2. Healthcare-associated Infections (HAI) Testing
7.2.3. Hepatitis Testing
7.2.3.1. Hepatitis B
7.2.3.2. Hepatitis C
7.2.4. Tropical Diseases Testing
7.2.5. HIV Testing
7.2.6. Respiratory Diseases Testing (other than Influenza and COVID-19)
7.2.7. Influenza Testing
7.2.8. Sexually Transmitted Diseases (STD) Testing
7.2.9. Other Infectious Diseases Testing
7.3. Pregnancy & Fertility Testing
7.4. Cardiac Metabolism Testing
7.5. Cholesterol Testing
7.6. Tumor/Cancer Markers Testing
7.7. Blood Glucose Testing
7.8. Urinalysis
7.9. Hematology Testing
7.10. Other Tests
8. Rapid Diagnostics Market, by End User
8.1. Introduction
8.2. Hospital & Clinics
8.3. Diagnostic Laboratories
8.4. Home Care/Self-testing
8.5. Other End Users
9. Rapid Diagnostics Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2021)
10.4.1. Abbott Laboratories (U.S.)
10.4.2. Becton, Dickinson and Company (U.S.)
10.4.3. F. Hoffmann-La Roche Ltd. (Switzerland)
11. Company Profiles (Business Overview, Financial Overview, Products Portfolio, Strategic Developments)
11.1. Abbott Laboratories
11.2. Becton, Dickinson and Company (BD)
11.3. Bio-Rad Laboratories, Inc.
11.4. F. Hoffmann-La Roche Ltd
11.5. ACON Laboratories, Inc.
11.6. Creative Diagnostics
11.7. Danaher Corporation
11.8. Thermo Fisher Scientific Inc.
11.9. BioMérieux S.A.
11.10. Alfa Scientific Designs, Inc.
11.11. BTNX Inc.
11.12. Meridian Bioscience, Inc.
11.13. Trinity Biotech plc
12. Appendix
12.1. Questionnaire
12.2. Available Customization
List of Tables
Table 1 Rapid Diagnostics Market: Impact Analysis of Market Drivers (2022–2029)
Table 2 Diabetes Prevalence in People Aged 65 Years and Above, by Region (2017 Vs. 2019 Vs. 2030)
Table 3 Number of People Aged 65 Years and Above, by Region, 2019 Vs. 2050 (in Million)
Table 4 Rapid Diagnostics Market: Impact Analysis of Market Restraints (2022–2029)
Table 5 Percentage of Population Residing in Urban Areas (Emerging Countries)
Table 6 Some of the Emergency Use Authorizations (EUAs) Granted for Rapid Diagnostics During the COVID-19 Pandemic
Table 7 Global Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 8 Global Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 9 Global Rapid Diagnostic Kits Market Size, by Country/Region, 2020–2029 (USD Million)
Table 10 Global Professional Rapid Diagnostic Kits Market Size, by Country/Region, 2022–2029 (USD Million)
Table 11 Prevalence of Diabetes, by Region, 2019–2045 (in Million)
Table 12 Global OTC Rapid Diagnostic Kits Market Size, by Country/Region, 2020–2029 (USD Million)
Table 13 Key Companies Offering Test Readers/Analyzers
Table 14 Global Rapid Diagnostics Equipment Market Size, by Country/Region, 2020–2029 (USD Million)
Table 15 Global Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 16 Global Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 17 Global Immunoassays Market Size, by Country/Region, 2020–2029 (USD Million)
Table 18 Recently Launched Lateral Flow Assays Kits for COVID-19 Testing
Table 19 Key Companies Offering Lateral Flow Assays
Table 20 Global Lateral Flow Assays Market Size, by Country/Region, 2020–2029 (USD Million)
Table 21 Key Companies Offering Serological Tests
Table 22 Global Serological Tests Market Size, by Country/Region, 2020–2029 (USD Million)
Table 23 Global Other Immunoassays Market Size, by Country/Region, 2020–2029 (USD Million)
Table 24 Top Countries with the Highest Search Volume Index for Reverse Transcription-Polymerase Chain Reaction Tests (2020–2021)
Table 25 Key Companies Offering Rapid Pcr Test Kits
Table 26 Global Molecular Detection Tests Market Size, by Country/Region, 2020–2029 (USD Million)
Table 27 Global Other Rapid Diagnostic Platforms Market Size, by Country/Region, 2020–2029 (USD Million)
Table 28 Global Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 29 Global Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 30 Key Companies Offering Rapid Diagnostic Kits for Infectious Diseases Testing
Table 31 Global Rapid Diagnostics Market Size for Infectious Diseases Testing, By Country/Region, 2020–2029 (USD Million)
Table 32 Some of the Recently Launched and Approved Rapid Diagnostic Tests for COVID-19 Detection
Table 33 Global Rapid Diagnostics Market Size for COVID-19 Testing, Country/Region, 2020–2029 (USD Million)
Table 34 Global Rapid Diagnostics Market Size for Healthcare-Associated Infections (HAI) Testing, by Country/Region, 2020–2029 (USD Million)
Table 35 Global Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 36 Global Rapid Diagnostics Market Size for Hepatitis Testing, by Country/Region, 2020–2029 (USD Million)
Table 37 Global Rapid Diagnostics Market Size for Hepatitis B Testing, by Country/Region, 2020–2029 (USD Million)
Table 38 Global Rapid Diagnostics Market Size for Hepatitis C Testing, by Country/Region, 2020–2029 (USD Million)
Table 39 Incidence of Tropical Diseases (2019)
Table 40 Global Rapid Diagnostics Market Size for Tropical Diseases Testing, By Country/Region, 2020–2029 (USD Million)
Table 41 HIV Prevalence by Region (2020)
Table 42 Global Rapid Diagnostics Market Size for HIV Testing, by Country/Region, 2020–2029 (USD Million)
Table 43 Global Rapid Diagnostics Market Size for Respiratory Diseases Testing, By Country/Region, 2020–2029 (USD Million)
Table 44 Global Rapid Diagnostics Market Size for Influenza Testing, by Country/Region, 2020–2029 (USD Million)
Table 45 Global Rapid Diagnostics Market Size for Sexually Transmitted Diseases (STD) Testing, by Country/Region, 2020–2029 (USD Million)
Table 46 Global Rapid Diagnostics Market Size for Other Infectious Diseases Testing, by Country/Region, 2020–2029 (USD Million)
Table 47 Countries with High Fertility Rates
Table 48 Key Companies Offering Rapid Diagnostic Kits for Pregnancy & Fertility Testing
Table 49 Global Rapid Diagnostics Market Size for Pregnancy & Fertility Testing, by Country/Region, 2020–2029 (USD Million)
Table 50 Key Companies Offering Rapid Diagnostic Kits for Cardiac Metabolism Testing
Table 51 Global Rapid Diagnostics Market Size for Cardiac Metabolism Testing, by Country/Region, 2020–2029 (USD Million)
Table 52 Global Rapid Diagnostics Market Size for Cholesterol Testing, by Country/Region, 2020–2029 (USD Million)
Table 53 Key Companies Offering Tumor/Cancer Marker Testing Products
Table 54 Global Rapid Diagnostics Market Size for Tumor/Cancer Markers Testing, By Country/Region, 2020–2029 (USD Million)
Table 55 Number of People with Diabetes Aged 20–79 Years, by Region, 2019 Vs. 2030 Vs. 2045 (in Million)
Table 56 Global Rapid Diagnostics Market Size for Blood Glucose Testing, By Country/Region, 2020–2029 (USD Million)
Table 57 Global Rapid Diagnostics Market Size for Urinalysis, by Country/Region, 2020–2029 (USD Million)
Table 58 Global Rapid Diagnostics Market Size for Hematology Testing, by Country/Region, 2020–2029 (USD Million)
Table 59 Global Rapid Diagnostics Market Size for Other Tests, by Country/Region, 2020–2029 (USD Million)
Table 60 Global Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 61 Global Rapid Diagnostics Market Size for Hospitals & Clinics, by Country/Region, 2020–2029 (USD Million)
Table 62 Global Rapid Diagnostics Market Size for Diagnostic Laboratories, By Country/Region, 2020–2029 (USD Million)
Table 63 Global Rapid Diagnostics Market Size for Home Care/Self-Testing, By Country/Region, 2020–2029 (USD Million)
Table 64 Global Rapid Diagnostics Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million)
Table 65 Global Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 66 North America: Rapid Diagnostics Market Size, by Country, 2020–2029 (USD Million)
Table 67 North America: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 68 North America: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 69 North America: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 70 North America: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 71 North America: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 72 North America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million)
Table 73 North America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 74 North America: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 75 Rapid Diagnostic Kits Launched for Coronavirus Testing
Table 76 U.S.: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 77 U.S.: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 78 U.S.: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 79 U.S.: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 80 U.S.: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 81 U.S.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 82 U.S.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 83 U.S.: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 84 Canada: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 85 Canada: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 86 Canada: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 87 Canada: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 88 Canada: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 89 Canada: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 90 Canada: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 91 Canada: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 92 Europe: Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 93 Europe: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 94 Europe: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 95 Europe: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 96 Europe: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 97 Europe: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 98 Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 99 Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 100 Europe: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 101 Recent Initiatives by the German Government to Tackle the Coronavirus Pandemic
Table 102 Germany: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 103 Germany: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 104 Germany: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 105 Germany: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 106 Germany: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 107 Germany: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 108 Germany: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 109 Germany: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 110 U.K.: Number of Chlamydia Tests Conducted, 2018–2019
Table 111 Recent Initiatives by the U.K. Government to Combat the COVID-19 Pandemic
Table 112 U.K.: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 113 U.K.: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 114 U.K.: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 115 U.K.: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 116 U.K.: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 117 U.K.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 118 U.K.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 119 U.K.: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 120 France: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 121 France: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 122 France: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 123 France: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 124 France: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 125 France: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 126 France: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 127 France: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 128 Initiatives Undertaken by the Government of Italy to Tackle the COVID-19 Pandemic
Table 129 Italy: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 130 Italy: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 131 Italy: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 132 Italy: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 133 Italy: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 134 Italy: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 135 Italy: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 136 Italy: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 137 Spain: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 138 Spain: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 139 Spain: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 140 Spain: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 141 Spain: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 142 Spain: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 143 Spain: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 144 Spain: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 145 Rest of Europe: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 146 Rest of Europe: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 147 Rest of Europe: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 148 Rest of Europe: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 149 Rest of Europe: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 150 Rest of Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million)
Table 151 Rest of Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 152 Rest of Europe: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 153 Asia-Pacific: Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 154 Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 155 Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 156 Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 157 Asia-Pacific: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 158 Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 159 Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million)
Table 160 Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 161 Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 162 China: Mass Testing Drives to Control the Spread of COVID-19 Infections
Table 163 China: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 164 China: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 165 China: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 166 China: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 167 China: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 168 China: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 169 China: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 170 China: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 171 Japan: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 172 Japan: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 173 Japan: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 174 Japan: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 175 Japan: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 176 Japan: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 177 Japan: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 178 Japan: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 179 Recent Initiatives Launched by the Government of India to Combat the COVID-19 Pandemic
Table 180 India: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 181 India: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 182 India: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 183 India: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 184 India: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 185 India: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 186 India: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 187 India: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 188 Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 189 Rest of Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 190 Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 191 Rest of Asia-Pacific: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 192 Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 193 Rest of Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 194 Rest of Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 195 Rest of Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 196 Latin America: Number of New HIV Cases, by Country (2019)
Table 197 Latin America: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 198 Latin America: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 199 Latin America: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 200 Latin America: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 201 Latin America: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 202 Latin America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million)
Table 203 Latin America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 204 Latin America: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 205 Middle East & Africa: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 206 Middle East & Africa: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 207 Middle East & Africa: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 208 Middle East & Africa: Immunoassays Market Size, by Type, 2020–2029 (USD Million)
Table 209 Middle East & Africa: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 210 Middle East & Africa: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 211 Middle East & Africa: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million)
Table 212 Middle East & Africa: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 213 Recent Developments, by Company, 2018–2021
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2022 (USD Million)
Figure 8 Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million)
Figure 9 Global Rapid Diagnostics Market Size, By Application, 2029 Vs. 2022 (USD Million)
Figure 10 Global Rapid Diagnostics Market Size, By End User, 2022 Vs. 2029 (USD Million)
Figure 11 Global Rapid Diagnostics Market, By Geography
Figure 12 Market Dynamics
Figure 13 Global Percentage Share of The Population Aged 65 and Above (2010–2020)
Figure 14 U.S.: Hepatitis A Virus (HAV) Infections (2013–2020)
Figure 15 EU Regulatory Pathway - IVDR 2017/746
Figure 16 Chinese Medical Device Classification and Pre-Market Requirements for Rapid Diagnostic Devices
Figure 17 Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2029 (USD Million)
Figure 18 Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million)
Figure 19 Reverse Transcription-Polymerase Chain Reaction: Global Search Volume Index
Figure 20 Global Rapid Diagnostics Market Size, By Application, 2022 Vs. 2029 (USD Million)
Figure 21 U.S.: Estimated Acute Hepatitis C Cases, 2011–2020
Figure 22 Estimated Number of New Cancer Cases, By Region, 2020–2040 (in Million)
Figure 23 Total Number of Accredited Testing Laboratories (Iso/Iec 17025), 2016–2020
Figure 24 Prevalence of Diabetes Across The World (in Million)
Figure 25 Global Rapid Diagnostics Market Size, By End User, 2022–2029 (USD Million)
Figure 26 U.S.: Home Healthcare Spending, 2015–2026 (USD Million)
Figure 27 Global Rapid Diagnostics Market Size, By Region, 2022 Vs. 2029 (USD Million)
Figure 28 North America: Rapid Diagnostics Market Snapshot
Figure 29 U.S.: Number of HIV-Positive Patients, 2017–2020
Figure 30 Canada: Number of People Aged 65 Years and Above, 2016–2020
Figure 31 Canada: Number of Inpatient Admissions in Acute-Care Hospitals, 2016–2020 (Per 1,00,000 Population)
Figure 32 Europe: Rapid Diagnostics Market Snapshot
Figure 33 U.K: Estimated Number of Cancer Cases, 2010–2030 (in Million)
Figure 34 U.K.: Number of Diabetes and Urogenital, Blood, and Endocrine Disease Cases - DALYS (Disability-Adjusted Life Years), 2017 2020 (in Thousand)
Figure 35 U.K.: Number of People Diagnosed With Sexually Transmitted Infections, 2018–2020 (in Thousand)
Figure 36 France: Percentage of Population Aged 65 Years and Above, 2016–2020
Figure 37 France: Prevalence of Chronic Diseases in People Aged 65 and Above (2019)
Figure 38 Italy: Prevalence of Healthcare-Associated Infections in Acute-Care Wards, 2016–2019
Figure 39 Italy: Ovarian Cancer Cases Diagnosed, 2018–2020
Figure 40 Italy: Total Number of New Diagnostic Laboratories for BRCA1/2 Testing, 2010–2019
Figure 41 Number of Hiv Tests Performed in Catalonia (Spain), 2014–2020
Figure 42 Asia-Pacific: Rapid Diagnostics Market Snapshot
Figure 43 China: Independent Medical Laboratories Market, 2015–2019 (USD Million)
Figure 44 Japan: Percentage Growth in The Aging Population (2015–2021)
Figure 45 Key Growth Strategies Adopted By Leading Players (2018–2021)
Figure 46 Rapid Diagnostics Market: Competitive Benchmarking
Figure 47 Market Share Analysis: Rapid Diagnostics Industry (2021)
Figure 48 Abbott Laboratories: Financial Overview (2021)
Figure 49 Becton, Dickinson and Company: Financial Overview (2021)
Figure 50 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
Figure 51 F. Hoffmann-La Roche Ltd: Financial Overview (2021)
Figure 52 Danaher Corporation: Financial Overview (2021)
Figure 53 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 54 BioMérieux S.A.: Financial Overview (2020)
Figure 55 Meridian Bioscience, Inc.: Financial Overview (2021)
Figure 56 Trinity Biotech plc: Financial Overview (2020)
This report provides pre & post COVID-19 market estimates.
IDT
This report provides pre & post COVID-19 market estimates.
IDT
Published Date: Feb-2024
Published Date: Jan-2024
Published Date: Feb-2023
